Antimicrobial drug discovery through bacteriophage genomics

Area of Science:

• Microbiology and Molecular Biology
• Drug Discovery and Development
• Bacteriophage Research

Background:

• Bacteriophages (phages) possess proteins that halt bacterial cellular functions to favor phage replication.
• This phage-mediated growth inhibition mechanism offers a novel avenue for antibiotic discovery.

Purpose of the Study:

• To explore the potential of phage-derived proteins as a source for new antibiotic agents.
• To identify and characterize novel polypeptide families from Staphylococcus aureus phages that inhibit bacterial growth.

Main Methods:

• Sequencing of 26 Staphylococcus aureus phages.
• Expression of identified phage polypeptides in S. aureus to assess growth inhibition.
• Identification of cellular targets for inhibitory polypeptides, focusing on DNA replication and transcription machinery.
• Screening for small molecule inhibitors based on phage protein-host target interactions (e.g., ORF104 and DnaI).

Main Results:

• Identification of 31 novel polypeptide families from S. aureus phages that inhibit bacterial growth.
• Several identified polypeptides target essential components of the host DNA replication and transcription systems.
• Discovery of small molecule compounds that inhibit both bacterial growth and DNA synthesis, inspired by phage protein interactions.

Conclusions:

• Phage-derived polypeptides represent a promising source for discovering novel antibacterial agents.
• Mimicking phage growth inhibition mechanisms with chemical compounds can lead to new antibiotics against infectious diseases.